ASE Test boosts Ainos (AIMD) 6% convertible note holdings to 105,868 units
Rhea-AI Filing Summary
ASE Test, Inc., a 10% owner of Ainos, Inc., reported an open-market purchase of 6% Convertible Notes due 2027. The transaction covers 5,994 units of the note, each currently convertible into Ainos common stock at a $22.50 per share conversion price. Following this transaction, ASE Test, Inc. holds 105,868 units of the convertible note. The notes bear 6% compounded interest and have a maturity date extended to March 12, 2027 under an amended agreement.
Positive
- None.
Negative
- None.
Insights
ASE Test increased its 6% convertible note position in Ainos on favorable amended terms.
ASE Test, Inc. bought 5,994 additional units of Ainos’ 6% Convertible Note due 2027, an instrument that can be converted into common stock at a price tied to trading levels but floored at $22.50 per share after a reverse split.
The note’s maturity was extended to March 12, 2027, and interest accrues at 6% compounded, which adds a fixed-income element alongside potential equity upside via conversion. After this purchase, ASE Test holds 105,868 note units, consolidating its role as a significant financing counterparty.
The eventual impact depends on whether ASE Test elects to convert notes into equity or hold them to maturity under the amended pricing formula and anti-dilutive adjustments described in the agreement.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | 6% Convertible Note due 2027 (previously due 2025) | 5,994 | $0.00 | -- |
Footnotes (1)
- The convertible notes with respect to shares of common stock, $0.01 par value (the "Common Stock"), of Ainos, Inc., a Texas corporation (the "Issuer") reported herein are directly held by ASE Test, Inc., an indirectly wholly-owned subsidiary of ASE Technology Holding Co., Ltd. Accordingly, ASE Technology Holding Co., Ltd. is reporting indirect ownership of the securities held by ASE Test, Inc. As previously reported, the Issuer and ASE Test, Inc. entered into a Convertible Note and Warrant Purchase Agreement, dated March 13, 2023 (the "2023 Convertible Note"), pursuant to which the Issuer issued convertible promissory notes to ASE Test, Inc. in the principal amount of $2,000,000 (the "Principal Amount") and six percent (6%) compounded interest of which was due on March 13, 2025. On March 10, 2025, the Issuer and ASE Test, Inc. entered into an amendment to the 2023 Convertible Note (the "Amended Convertible Note") to extend the maturity date to March 12, 2027 and change the conversion price from $7.50 per share to a conversion price equal to the lower of (a) $7.50 per share and (b) the higher of (x) the average closing price per share of the Issuer's common stock for the period of thirty (30) trading days prior to the day when the noteholder exercises the conversion right or (y) $4.50, subject to anti-dilutive adjustment as set forth in the Amended Convertible Note. As a result of the five-for-one reverse stock split effected by the Issuer on June 30, 2025, the conversion price is now the lower of (a) $37.50 per share and (b) the higher of (x) the average closing price per share of the Issuer's common stock for the period of thirty (30) trading days prior to the day when the noteholder exercises the conversion right or (y) $22.50, subject to anti-dilutive adjustment as set forth in the Amended Convertible Note.